Diabetes insipidus in craniopharyngioma: postoperative management of water and electrolyte disorders

J Pediatr Endocrinol Metab. 2006 Apr:19 Suppl 1:413-21.

Abstract

Pre-operative central diabetes insipidus has been reported in 8-35% of patients affected with craniopharyngioma, and in 70-90% after surgery. The management of postoperative polyuria and polydipsia can be challenging and fluid balance needs to be closely monitored. The classical triphasic pattern of endogenous vasopressin secretion--an initial phase of symptomatic diabetes insipidus occurring 24 hours after surgery; a second phase of inappropriate vasopressin secretion potentially causing hyponatraemia; and a third phase with a return to diabetes insipidus occurring up to 2 weeks later--is often complicated by cerebral salt wasting and thirst disorders. Inadequate adrenal replacement therapy and anticonvulsant agent treatment may increase the risk of life-threatening hyponatraemia in the course of desmopressin (DDAVP) treatment. Appropriate management, in order to avoid life-threatening or disabling electrolyte disturbances, requires a good grasp of the relevant pathophysiology. We review here the pathophysiology and management of the multiple fluid disorders encountered following surgery for craniopharyngiomas.

Publication types

  • Review

MeSH terms

  • Child
  • Craniopharyngioma / complications*
  • Craniopharyngioma / surgery
  • Diabetes Insipidus / diagnosis
  • Diabetes Insipidus / etiology*
  • Diabetes Insipidus / therapy*
  • Humans
  • Hyponatremia / etiology
  • Hyponatremia / therapy
  • Neurosurgical Procedures
  • Pituitary Neoplasms / complications*
  • Pituitary Neoplasms / surgery
  • Postoperative Complications / diagnosis
  • Postoperative Complications / therapy*
  • Thirst
  • Vasopressins / antagonists & inhibitors
  • Water-Electrolyte Imbalance / diagnosis
  • Water-Electrolyte Imbalance / etiology*
  • Water-Electrolyte Imbalance / therapy*

Substances

  • Vasopressins